CLGN

AS OF

Apr 3 closing price

Price

$2.46

Change

-$0.12 (-4.65%)

Capitalization

28.18M

48 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

CLGN Stock CLGN is expected to report earnings to rise+28% to -28 cents per share on March 26

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

CLGN - CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd Earnings Graph

Q4'24

Est.

$-0.28

Q3'24

Missed

by $0.09

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.02

Q4'23

Missed

by $0.29

The last earnings report on September 30 showed earnings per share of -38 cents, missing the estimate of -29 cents. P/B Ratio (2.099) is normal, around the industry mean (13.748). P/E Ratio (0.000) is within average values for comparable stocks, (66.552). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.951). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (54.645) is also within normal values, averaging (240.698). With 69.28K shares outstanding, the current market capitalization sits at 35.51M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of medical devices

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4 Oppenheimer Street

Phone

+972 732325600

Employees

Web

https://www.collplant.com